While murine studies have suggested that host-derived MIF drives tumor progression more than tumor-derived MIF, clinical data has correlated high stromal MIF expression with worse survival outcomes and can offer deeper mechanistic insight into its role at the site of tumor development [28, 30, 31]. The gene discussed is MIF; the disease is neoplasm.